tetano
Editor, Senior Moderator
BMC Public Health. 2014 Jan 20;14(1):56. [Epub ahead of print]
Economic burden of seasonal influenza B in France during winter 2010-2011.
Silva ML, Perrier L, Sp?th HM, Grog I, Mosnier A, Havet N, Cohen JM.
Abstract
BACKGROUND:
In France, 2-15% of the population is affected annually by influenza, which causes significant socioeconomic disruption. Nevertheless, despite its importance for policy makers, few published studies have evaluated the impact of influenza B. Therefore, we assessed the costs associated with influenza B during 2010-2011 in France.
METHODS:
Cases of lab-confirmed influenza B were analyzed as part of the Influenza B in General Practice Study. Cost calculations were based on micro-costing methods according to the French Health Insurance (FHI) perspective (in Euros, 2011). Costs were compared between age groups using the Kruskal-Wallis test, and when significant, by multiple comparisons based on rank. Moreover, uncertainties were assessed using one-way sensitivity and probabilistic analyses. Overall economic burden was estimated by multiplying cost per patient, flu attack rate, and the French population.
RESULTS:
A total of 201 patients were included in the study. We found that the mean cost associated with Influenza B was 72[euro sign] (SD: 205) per patient: 70[euro sign] (SD: 262) for younger children, 50[euro sign] (SD: 195) for older children, 126[euro sign] (SD: 180) for adults, and 42[euro sign] (SD: 18) for elderly. Thus, we observed significantly different costs between the distinct age groups (p<0.0001). Finally, the economic burden of influenza B for the FHI was estimated to be 145 million Euros (95% CI: 88-201).
CONCLUSIONS:
Our findings highlight the important impact of influenza B and encourage further investigation on policy regarding vaccination strategies in France.
PMID:
24443900
[PubMed - as supplied by publisher]
Free full text
http://www.ncbi.nlm.nih.gov/pubmed/24443900
Economic burden of seasonal influenza B in France during winter 2010-2011.
Silva ML, Perrier L, Sp?th HM, Grog I, Mosnier A, Havet N, Cohen JM.
Abstract
BACKGROUND:
In France, 2-15% of the population is affected annually by influenza, which causes significant socioeconomic disruption. Nevertheless, despite its importance for policy makers, few published studies have evaluated the impact of influenza B. Therefore, we assessed the costs associated with influenza B during 2010-2011 in France.
METHODS:
Cases of lab-confirmed influenza B were analyzed as part of the Influenza B in General Practice Study. Cost calculations were based on micro-costing methods according to the French Health Insurance (FHI) perspective (in Euros, 2011). Costs were compared between age groups using the Kruskal-Wallis test, and when significant, by multiple comparisons based on rank. Moreover, uncertainties were assessed using one-way sensitivity and probabilistic analyses. Overall economic burden was estimated by multiplying cost per patient, flu attack rate, and the French population.
RESULTS:
A total of 201 patients were included in the study. We found that the mean cost associated with Influenza B was 72[euro sign] (SD: 205) per patient: 70[euro sign] (SD: 262) for younger children, 50[euro sign] (SD: 195) for older children, 126[euro sign] (SD: 180) for adults, and 42[euro sign] (SD: 18) for elderly. Thus, we observed significantly different costs between the distinct age groups (p<0.0001). Finally, the economic burden of influenza B for the FHI was estimated to be 145 million Euros (95% CI: 88-201).
CONCLUSIONS:
Our findings highlight the important impact of influenza B and encourage further investigation on policy regarding vaccination strategies in France.
PMID:
24443900
[PubMed - as supplied by publisher]
Free full text
http://www.ncbi.nlm.nih.gov/pubmed/24443900